(Q28204294)

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206678

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206678

Ataxia telangiectasia mutated (ATM) kinase and ATM and Rad3 related kinase mediate phosphorylation of Brca1 at distinct and overlapping sites. In vivo assessment using phospho-specific antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206678

Developmental studies of Brca1 and Brca2 knock-out mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206678

BRCA1 and BRCA2--breast cancer susceptibility genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206678

Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206678

The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206678

Binding of CtIP to the BRCT repeats of BRCA1 involved in the transcription regulation of p21 is disrupted upon DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206678

Direct DNA binding by Brca1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206678

BRCA1 is a component of the RNA polymerase II holoenzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206678

Independence of R/M/N focus formation and the presence of intact BRCA1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206678

Deficiency of human BRCA2 leads to impaired homologous recombination but maintains normal nonhomologous end joining

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206678

BRCA1 Facilitates Stress-induced Apoptosis in Breast and Ovarian Cancer Cell Lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206678

Expression of BRC repeats in breast cancer cells disrupts the BRCA2-Rad51 complex and leads to radiation hypersensitivity and loss of G(2)/M checkpoint control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206678

7 January 2021

Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206678

7 January 2021

The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206678

7 January 2021

p53 mutation with frequent novel condons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206678

7 January 2021

p53 mutations in BRCA1-associated familial breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206678

7 January 2021

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206678

7 January 2021

BRCA1 required for transcription-coupled repair of oxidative DNA damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206678

7 January 2021

The fuss about Mus81.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206678

7 January 2021

Activation of transcription in vitro by the BRCA1 carboxyl-terminal domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206678

7 January 2021

The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206678

7 January 2021

Linkage of early-onset familial breast cancer to chromosome 17q21

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206678

7 January 2021

Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206678

7 January 2021

The expanding role of cell cycle regulators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206678

7 January 2021

Cancer-susceptibility genes. Gatekeepers and caretakers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206678

7 January 2021

BRCA1 effects on the cell cycle and the DNA damage response are linked to altered gene expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206678

7 January 2021

A human BRCA2 complex containing a structural DNA binding component influences cell cycle progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206678

7 January 2021

The BRCA2 activation domain associates with and is phosphorylated by a cellular protein kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206678

7 January 2021

BRCA2 is required for homology-directed repair of chromosomal breaks

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206678

7 January 2021

Insights into DNA recombination from the structure of a RAD51-BRCA2 complex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206678

7 January 2021

Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206678

7 January 2021

Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206678

7 January 2021

Novel p53 mutants selected in BRCA-associated tumours which dissociate transformation suppression from other wild-type p53 functions.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206678

7 January 2021

BRCA1 deficient embryonic stem cells display a decreased homologous recombination frequency and an increased frequency of non-homologous recombination that is corrected by expression of a brca1 transgene.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206678

7 January 2021

BRCA1 signals ARF-dependent stabilization and coactivation of p53.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206678

7 January 2021

Identification of the breast cancer susceptibility gene BRCA2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206678

7 January 2021

Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206678

7 January 2021

Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206678

7 January 2021

Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206678

7 January 2021